A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

NCT07476378 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, Large B-Cell, Diffuse (DLBCL)
Lymphoma, Follicular
Lymphoma, Mantle-Cell
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Lymphoma, B-Cell, Marginal Zone
Transformed Follicular Lymphoma (TFL)

Interventions

DRUG: MTM-H-001 Injection

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]